TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company based in San Diego, CA, dedicated to developing and commercializing targeted therapies for cancer and other high unmet medical needs. Their lead product candidate, envafolimab, is a PD-L1 antibody designed for the treatment of sarcoma.
With a focus on innovative therapeutics, TRACON Pharmaceuticals aims to be a leader in the field by advancing novel treatments to address the challenges faced by patients with cancer and other diseases. Through their pipeline and clinical trials, the company is committed to making a significant impact on the healthcare landscape.
Generated from the website